Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Open Access
- 8 August 2011
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 219 (1), 109-115
- https://doi.org/10.1016/j.atherosclerosis.2011.07.023
Abstract
No abstract availableKeywords
Funding Information
- Fonds zur Foerderung der Wissenschaftlichen Forschung (P1999-B05, NFN S10702)
This publication has 30 references indexed in Scilit:
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Cholesteryl Ester Transfer Protein and Mortality in Patients Undergoing Coronary AngiographyCirculation, 2010
- Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the CommunityCirculation, 2009
- Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid productionJournal of Lipid Research, 2009
- Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass graftsCardiovascular Research, 2009
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- Effect of Torcetrapib on Carotid Atherosclerosis in Familial HypercholesterolemiaNew England Journal of Medicine, 2007
- Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- Transluminal coronary angioplasty in the elderlyThe American Journal of Cardiology, 1986